Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sotera Health (SHC)
NASDAQ:SHC
Holding SHC?
Track your performance easily
Earnings Data
Report Date
Mar 04, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
0.2Last Year’s EPS
0.26Same Quarter Last Year
Moderate Buy
Based on 8 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:May 13, 2021
|% Change Since: -17.85%
|Next Earnings Date:Mar 09, 2021
Earnings Call Sentiment|Neutral
The earnings call presented a balanced view with significant revenue growth and operational milestones offset by specific segment challenges and regulatory pressures. The company's ability to grow in the face of foreign exchange headwinds and operational costs shows resilience, but ongoing litigation and regulatory challenges pose risks.Company Guidance
During the Sotera Health Q3 2024 earnings call, the company reaffirmed its full-year outlook, projecting revenue and adjusted EBITDA growth between 4% and 6%. The call highlighted several key performance metrics: total company revenues increased by 8.5% year-over-year, adjusted EBITDA rose by 9%, and adjusted EPS reached $0.17, up by $0.01 from the same quarter last year. Sterigenics, their largest segment, achieved 4.3% revenue growth, while Nordion's revenue surged by 28% due to favorable reactor harvest schedules. Nelson Labs saw a 7% increase in revenue, with segment income margins improving by 56 basis points to 31.8%. The company reported a net leverage ratio of 3.6x and maintained over $700 million in liquidity. Looking ahead, Sotera Health expects capital expenditures for 2024 to range between $175 million and $185 million, with peak CapEx anticipated in 2025.Total Revenue Growth
Total company revenues increased 8.5% year-over-year or 8.9% on a constant currency basis for the third quarter of 2024.
Significant Nordion Segment Growth
Nordion delivered a 28% year-over-year revenue increase due to the timing of reactor harvest schedules, leading to a 31.9% increase in segment income.
Nelson Labs Performance
Nelson Labs reported a 7% increase in revenue and a 9% increase in segment income with improved margins as core lab testing volumes increased.
Strong Liquidity Position
The company reported over $700 million of available liquidity, including $307 million of unrestricted cash and $400 million of available capacity on a revolving line of credit.
First Cobalt Insertion Milestone
Nordion achieved the first insertion of cobalt into a Darlington reactor in Canada, with the first Cobalt-60 harvest expected in 2028.
---
SHC Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
SHC Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 05, 2024 | $15.80 | $15.42 | -2.41% |
| Aug 05, 2024 | $13.22 | $14.22 | +7.56% |
| May 02, 2024 | $11.27 | $10.91 | -3.19% |
| Feb 27, 2024 | $17.06 | $17.34 | +1.64% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Sotera Health (SHC) report earnings?
Sotera Health (SHC) is schdueled to report earning on Mar 04, 2025, TBA Not Confirmed.
What is Sotera Health (SHC) earnings time?
Sotera Health (SHC) earnings time is at Mar 04, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is SHC EPS forecast?
SHC EPS forecast for the fiscal quarter 2024 (Q4) is 0.2.
---